Full panel assays test multiple pathogens accurately in a single run without any other method
When in many cases of death by gastrointestinal infections (food poisoning) caused by Salmonella and Listeria did not have clear answers on their causative pathogen identification1)2).
A. 1500 deaths occurs annually in US because of GI infection (food poisoning) caused by Salmonella and Listeria but 60% of them are attributed by unidentified pathogens.2)
B. 795 stool samples tested in Australia, 9 cases of salmonellosis, and 24 cases of campylobacteriosis were identified, when Salmonella and Listeria were tested only.3)
Seegene’s test for gastrointestinal infection highlights the benefits of full panel assays. The results of Noro(-) samples (N=200)3) with Seegene’s assay shows not only the single infection of GI pathogens but also double and triple co-infected pathogen information and its severity.
1) Gamarra RM et al. (updated 2015) https://emedicine.medscape.com/article/175569
2) Hellard M. et al. (2001) Environ Health Perspect. 109:774-784
3) Clinical evaluation of Allplex™ GI Assay (Oral presentation at 2016 ECCMID, Seegene integrated symposium)
Because Seegene’s assay simultaneously test for multiple targets in reduced running time with minimum labor required, it enables reduction of test cost and improve test productivity. Used of GI full panel proves that the test time is much shorter for both parasites and bacteria infections but labor and reagent/media cost is lower with higher sensitivity.
1) Post of instantlabs website, December 3rd, 2013 by Lauren Bambusch, 2) Oral presentation at 2016 ECCMID, Seegene integrated symposium
Unlike traditionally used gold standard method, Seegene’s full panel assays allow accurate in informative diagnosis when requires prompt treatment such as testing Tuberculosis (TB) and drug-resistances of TB.
“ We call current diagnostic process as the ‘Diagnostic cascade’. This term simply explains the current situation that some of relevant organisms are indeed being excluded during diagnostic process.”
“ Great performance with high clinical sensitivity and specificity! And, 63-fold of reductions in lab costs and expenses come with it.”